Konrad Klinghammer

8PUBLICATIONS
53CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 29, 2025
INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Jérôme Fayette, Lisa Licitra, Kevin Harrington

|Jan 21, 2022
Predictors for Adherence to Treatment Strategies in Elderly HNSCC Patients.

Raphaela Graessle, Carmen Stromberger, Max Heiland

|May 30, 2020
Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.

Clemens Messerschmidt, Benedikt Obermayer, Konrad Klinghammer

Pageof 2